Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) EPS (Weighted Average and Diluted): 2009-2025

Historic EPS (Weighted Average and Diluted) for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to $7.16.

  • UNITED THERAPEUTICS's EPS (Weighted Average and Diluted) rose 12.05% to $7.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $26.41, marking a year-over-year increase of 16.14%. This contributed to the annual value of $24.64 for FY2024, which is 24.38% up from last year.
  • UNITED THERAPEUTICS's EPS (Weighted Average and Diluted) amounted to $7.16 in Q3 2025, which was up 11.70% from $6.41 recorded in Q2 2025.
  • UNITED THERAPEUTICS's 5-year EPS (Weighted Average and Diluted) high stood at $7.16 for Q3 2025, and its period low was $0.61 during Q1 2021.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $6.17 (2024), whereas its average is $5.88.
  • In the last 5 years, UNITED THERAPEUTICS's EPS (Weighted Average and Diluted) slumped by 80.45% in 2021 and then surged by 724.59% in 2022.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's EPS (Weighted Average and Diluted) stood at $2.34 in 2021, then climbed by 13.25% to $2.65 in 2022, then spiked by 63.40% to $4.33 in 2023, then soared by 43.42% to $6.21 in 2024, then grew by 12.05% to $7.16 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $7.16 for Q3 2025, versus $6.41 for Q2 2025 and $6.63 for Q1 2025.